Research Article
Analysis of Serum IgG1 to Predict Progression and Therapeutic Effect in Patients with Multiple Myeloma
Table 6
Concentration of serum cytokines in patients with multiple myeloma.
| | Healthy control | Multiple myeloma | value |
| IL-2 (pg/ml, N = 57) | 0.60 ± 1.23 | 2.08 ± 4.38 | <0.0762 | IL-4 (pg/ml, N = 57) | 0.44 ± 0.83 | 2.13 ± 3.92 | <0.0226 | IL-6 (pg/ml, N = 57) | 0.38 ± 0.64 | 10.18 ± 14.67 | <0.0005 | TNF-α (pg/ml, N = 57) | 1.52 ± 1.39 | 4.08 ± 6.88 | <0.0268 | IFN-γ (pg/ml, N = 57) | 0.44 ± 1.34 | 4.06 ± 7.16 | <0.0075 | CRP (μg/ml, N = 560) | 3.21 ± 1.81 | 47.67 ± 66.26 | <0.0001 |
|
|